Riyasat IAS Mentorship Team
Updated 19 Jul 2026
6 min read
Non-Tariff Barriers (NTBs) and Global Trade
GS Paper 2/3 | International Trade | India’s Economy | WTO | FTA Utilisation
Why in the News? In February 2026, India and the United States agreed on the framework of an interim trade agreement — covering tariff cuts (US duties down to 18%, India moving toward zero duty on certain US goods). However, the more strategically significant element is the negotiation to remove Non-Tariff Barriers (NTBs) — the “silent weapons” that have become the real roadblocks in modern global trade.
What Are Non-Tariff Barriers (NTBs)?
Government regulations, policies, or certifications that regulate or restrict the entry of goods into a country — without using a direct tax/duty mechanism. They fall into two primary categories:
Category
Definition
SPS (Sanitary and Phytosanitary Measures)
Stringent regulations related to human, animal, or plant health and safety — e.g., pesticide residue limits, food safety standards
Tariffs vs. Non-Tariff Barriers: The Key Distinction
Tariffs
Non-Tariff Barriers (NTBs)
Transparent and easy to measure (e.g., a flat 10% duty)
Function as “silent weapons” — embedded in regulatory and technical systems
Visible in trade negotiations and headlines
Often invisible in headline agreements but drive the actual cost of market access
Impact is uniform across exporters of similar capacity
Disproportionately burden small exporters from developing nations due to high compliance costs
Why Has Global Trade Shifted from Tariffs to Regulations?
Since WTO’s establishment in 1995, global average tariff rates have been cut nearly in half — but nations did not abandon protectionism; they replaced tariffs with NTBs, which now affect nearly 90% of global trade
Of roughly 20,000 global product regulations introduced over the last 70 years, more than half were introduced after 2000 — showing a sharp acceleration in regulatory protectionism this century
In 2025 alone, governments sent over 7,700 new NTB-related notifications to the WTO — indicating the pace of regulatory complexity is still increasing, not stabilising
How Major Economies Use NTBs Strategically
Economy
Coverage
Strategic Focus
European Union
94% of imports
Most extensive regulatory user — deploys environment, chemical safety, and climate policy as protective shields (e.g., CBAM — Carbon Border Adjustment Mechanism; EUDR — EU Deforestation Regulation)
United States
77% of imports
Focused on strategic competition and technological dominance — export controls on semiconductors, AI chips, and advanced hardware
India
45% of imports
Traditionally tariff-reliant, now expanding Quality Control Orders (QCOs) on electronics, machinery, and chemicals under “Atmanirbhar Bharat” domestic industrial strategy
The FTA Utilisation Gap: Why Paper Agreements Don’t Translate to Real Trade
India’s average FTA utilisation rate stands at a meagre 25% — compared to 70-80% for developed nations. This means Indian exporters fail to claim the preferential tariff benefits negotiated on paper, primarily because NTBs erect a second, hidden barrier after the tariff barrier is removed.
UPSC Note Logical chain: Paper Agreement (Tariff Reduction) → Ground Reality (Non-Tariff Barriers) → Result (Low FTA Utilisation Rate ~25%). This three-step framework is a useful answer-writing structure for Mains questions on trade agreement effectiveness.
Case Studies: Where India’s FTAs Have Underperformed
FTA
Underperformance Evidence
ASEAN (2010)
Utilisation rate below 50% despite the agreement being in place. Indian pharmaceutical exports restricted by Indonesia’s stringent registration norms; Thailand’s complex customs procedures force jewellery exporters to route shipments through Hong Kong
Japan FTA (2011)
Indian pharma exports remain negligible — market clearance takes 5-7 years, and Japan does not recognise Indian testing standards
South Korea FTA (2011)
Bilateral trade reached $27 billion, but India’s export share remained stuck at just $6.5 billion (~24%)
Historic because it grants automatic recognition to Indian medicines approved by major global regulators (USFDA, EMA). Mutual acceptance of laboratory tests eliminates duplicate testing costs — directly solving the NTB problem rather than just cutting tariffs.
India-EFTA TEPA (Effective October 2025)
Emphasises mutual recognition of standards and establishes a dedicated legal sub-committee to continuously address NTB issues. For the first time, minimising non-tariff barriers has become a legally binding obligation in an Indian FTA — not just an aspirational clause.
The Way Forward
Mutual Recognition Agreements (MRAs): Prioritise negotiating mutual recognition of testing laboratories and product certifications with key partners (US, EU, UK) — enforcing the principle of “tested once, accepted everywhere”
Upgrading Standards: Harmonise Indian standards (BIS) with international standards (ISO/IEC) so Indian products are not rejected abroad on technical grounds
Institutional Capacity Building: Establish a dedicated “Trade Intelligence and Support Center” to educate MSMEs and small exporters on complex technical/environmental mandates (e.g., EU’s CBAM)
Strategic Use of the WTO Forum: India, with like-minded developing nations, should raise the “hidden protectionism” practised under the guise of environment and safety standards
Key Terms for UPSC
Term
Definition
CBAM (Carbon Border Adjustment Mechanism)
EU mechanism imposing carbon costs on imports based on their carbon footprint — effectively a climate-linked NTB
EUDR (EU Deforestation Regulation)
EU regulation requiring proof that imported commodities (palm oil, soy, coffee, etc.) are not linked to deforestation
QCO (Quality Control Order)
Indian regulatory mechanism mandating BIS certification for specified products before sale or import
MRA (Mutual Recognition Agreement)
Bilateral/multilateral agreement where two countries recognise each other’s testing, certification, or regulatory standards — eliminating duplicate compliance costs
FTA Utilisation Rate
The percentage of eligible trade that actually claims preferential tariff treatment under a Free Trade Agreement — low utilisation indicates NTBs or procedural barriers are blocking real benefit capture
Practice Question“In contemporary global trade diplomacy, the nature of protectionism has shifted from traditional tariffs to more complex and invisible Non-Tariff Barriers.” Examine this statement in the context of recent Free Trade Agreements (FTAs) and discuss its impact on Indian exports. (15 Marks, 250 Words)
📝 Practice MCQWith reference to Non-Tariff Barriers (NTBs) in global trade, consider the following statements: 1. Sanitary and Phytosanitary (SPS) measures relate to technical product regulations, packaging, and labelling rules. 2. India’s average Free Trade Agreement utilisation rate is significantly lower than that of developed nations. 3. The India-UAE CEPA grants automatic recognition to Indian medicines approved by major global regulators such as the USFDA. Which of the statements given above is/are correct? (A) 1 and 2 only (B) 2 and 3 only (C) 1 and 3 only (D) 1, 2 and 3 Answer: (B) 2 and 3 only — Statement 1 is incorrect: SPS measures relate to human, animal, and plant health and safety regulations (e.g., pesticide residue limits); technical regulations, packaging, and labelling rules fall under Technical Barriers to Trade (TBT), a separate category.
